Publication Venue For
Primary and secondary breast angiosarcoma: single center report and a meta-analysis.
Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review.
Adult weight gain accelerates the onset of breast cancer.
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
Circulating microRNAs from the miR-106a–363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Evaluation of [ 89 Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.
Speed of processing in middle aged and older breast cancer survivors (SOAR): A feasibility study.
Speed of processing training in middle-aged and older breast cancer survivors (SOAR): results of a randomized controlled pilot.
Ethnicity and breast cancer characteristics in Kenya.
Healthcare utilization, Medicare spending, and sources of patient distress identified during implementation of a lay navigation program for older patients with breast cancer.
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.
Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008.
Effects of a multicomponent physical activity behavior change intervention on breast cancer survivor health status outcomes in a randomized controlled trial.
Weight gain during adjuvant endocrine treatment for early-stage breast cancer: What is the evidence?.
Great tumour burden in the axilla may influence lymphatic drainage in breast cancer patients.
Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro.
Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors.
PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers.
Taking the next step: a systematic review and meta-analysis of physical activity and behavior change interventions in recent post-treatment breast cancer survivors.
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007.
Recurrent read-through fusion transcripts in breast cancer.
TBCRC 018: Phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.
DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells.
Multivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the women's health initiative.
Time-trends in survival in young women with breast cancer in a SEER population-based study.
Advanced cognitive training for breast cancer survivors: A randomized controlled trial.
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.
Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity.
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
Bone metastasis in a novel breast cancer mouse model containing human breast and human bone.
Chemotherapy response and recurrence-free survival in Neoadjuvant breast cancer depends on biomarker profiles: Results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
Locally advanced breast cancers are more likely to present as interval cancers: Results from the I-SPY 1 TRIAL (CALGB 150007/150012, acrin 6657, interSPORE trial).
Bloody nipple discharge is a predictor of breast cancer risk: A meta-analysis.
Adjuvant therapy for HER2+ breast cancer: Practice, perception, and toxicity.
Mortality following bone metastasis and skeletal-related events among women with breast cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999-2006.
Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: Results of four randomized trials.
Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI).
A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: In vitro and in vivo activity and mechanisms of action.
Gli1 promotes cell survival and is predictive of a poor outcome in ERα-negative breast cancer.
A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment.
Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control.
Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.
Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer.
Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier.
Inhibin A and B as predictive markers for chemotherapy-induced premature ovarian failure (POF) among premenopausal women with early stage breast cancer (ESBC)..
Omega-3 fatty acids decrease protein kinase expression in human breast cancer cells.
The chemopreventive properties of soy isoflavonoids in animal models of breast cancer.
Gene therapy strategies for carcinoma of the breast.
Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer.
Prognostic relevance of transforming growth factor alpha (TGF-α) and tumor necrosis factor alpha (TNF-α) detected in breast cancer tissues by immunohistochemistry.
A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer - A Southeastern Cancer Study Group Project.
Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: The Southeastern Cancer Study Group experience.
A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer.
Multivariate prognostic factor analysis evaluating dose received in patients with advanced breast cancer treated with a doxorubicin combination.